T-Cell Project: Epidemiologic Component
|ClinicalTrials.gov Identifier: NCT00705809|
Recruitment Status : Completed
First Posted : June 26, 2008
Last Update Posted : July 2, 2017
- The T-Cell Project, sponsored by the International T-cell non-Hodgkin Lymphoma Study Group, is a consortium of institutions interested in achieving more detailed information on clinical and biological characteristics of T-cell lymphomas.
- The T-Cell Project serves as a repository for data on patients with peripheral T-cell lymphoma (PTCL) worldwide. Its overall goal is to improve T-cell subtype classifications and evaluate treatment strategies for each subtype.
-To implement a standardized epidemiologic questionnaire into the ongoing T-Cell Project to allow evaluation of various potential risk factors for PTLCs.
-Untreated patients 18 years of age and older who were diagnosed with PTLC September 1, 2006, or later.
-Patients complete a questionnaire containing the following information:
Smoking history and alcohol use
Personal history or cancer
History of cancer among first-degree relatives
History of transplants
History of blood transfusions
Occupational and residential history
-The information collected is linked to clinical and pathologic information in the T-Cell Project database.
|Condition or disease|
|Peripheral T-Cell Lymphoma|
|Study Type :||Observational|
|Estimated Enrollment :||800 participants|
|Official Title:||T-Cell Project: Epidemiologic Component|
|Study Start Date :||June 18, 2008|
|Study Completion Date :||July 20, 2011|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00705809
|United States, Maryland|
|National Cancer Institute (NCI), 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|